Literature DB >> 6298835

Effects of opiate antagonists and putative mu- and kappa-agonists on milk intake in rat and squirrel monkey.

K W Locke, D R Brown, S G Holtzman.   

Abstract

The effects of a number of relatively pure opiate antagonists (naloxone, naltrexone, diprenorphine), and putative mu- (morphine, etorphine) and kappa- (ketocyclazocine, ethylketocyclazocine) receptor agonists on sweetened condensed milk intake were examined over a broad range of doses in non-deprived rats and squirrel monkeys. The antagonists consistently decreased milk intake in both the rat and squirrel monkey. There were, however, species differences: diprenorphine was 30 times more potent than either naloxone or naltrexone in the squirrel monkey, but was of similar potency in the rat. The effects of the opiate agonists were more variable than those of the antagonists. In both species, all agonists decreased milk intake at high doses that also produced behavioral depression. Significant increases in drinking were produced only by low doses of ketocyclazocine and ethylketocyclazocine in the rat. The suppression of milk intake by the antagonists supports a modulatory role of opiate receptors in the control of drinking behavior, however, the effects of the agonists on drinking are less easily interpreted within this conceptual framework.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298835     DOI: 10.1016/0091-3057(82)90133-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

Review 1.  The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse.

Authors:  Sunmee Wee; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-03-30       Impact factor: 4.530

2.  Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male rats.

Authors:  S J Cooper; D J Barber; D B Gilbert; W R Moores
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Intracerebral injection of different antibodies against endogenous opioids suggests alpha-neoendorphin participation in control of feeding behaviour.

Authors:  R Schulz; A Wilhelm; G Dirlich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

4.  Ingestive behaviour of the pigeon: stereoselective influence of the opiate agonist levorphanol and its antagonism by naloxone.

Authors:  P Deviche; G Schepers
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Sensory and associative effects of morphine and naloxone in classical conditioning of the rabbit nictitating membrane response.

Authors:  C W Schindler; I Gormezano; J A Harvey
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Reinforcer interactions under concurrent schedules of food, water, and intravenous morphine.

Authors:  S I Dworkin; G F Guerin; N E Goeders; D R Cherek; J D Lane; J E Smith
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.

Authors:  Clifford C Michaels; Stephen G Holtzman
Journal:  Pharmacol Biochem Behav       Date:  2007-03-28       Impact factor: 3.533

8.  Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists.

Authors:  A H Oliveto; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

9.  Individual differences in locomotor reactivity to a novel environment and sensitivity to opioid drugs in the rat. II. Agonist-induced antinociception and antagonist-induced suppression of fluid consumption.

Authors:  David A White; Mikhail Kalinichev; Stephen G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  2004-07-02       Impact factor: 4.530

10.  The kappa-opioid U-50,488H suppresses the initiation of nocturnal spontaneous drinking in normally hydrated rats.

Authors:  A Badiani; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.